Enhanced 3,5-dihydroxyphenylglycine-induced sustained nociceptive behaviors in rats with neuropathy or chronic inflammation.
Sustained nociceptive behaviors (SNBs) are an important but under-studied component of chronic pain conditions. The group I metabotropic glutamate receptor (mGluR) agonist (R,S)-3,5-dihydroxyphenylglycine (DHPG) produces SNBs when injected intrathecally, and group I mGluR antagonists are effective at reducing symptoms of neuropathic and inflammatory pain. The present experiments examined whether rats with sciatic nerve injury or persistent inflammation exhibit greater SNBs following intrathecal DHPG compared with control animals. SNBs were observed following intrathecal injection of DHPG (25 nmol) between the L4 and L5 vertebrae. We used a behavioral observation scoring system that allowed for assessment of specific behaviors in the hind paws. When DHPG was injected intrathecally in rats with chronic constriction injury (CCI) of the sciatic nerve, they showed increased paw stamping behavior compared to DHPG-injected sham controls. Rats treated with complete Freund's adjuvant (CFA)-induced inflammation failed to demonstrate a significant increase in paw stamping behavior. However, both CCI and CFA rats showed increased paw licking and biting of the neuropathic/inflamed hind paw after intrathecal DHPG injection. These results provide evidence for behaviorally relevant contributions of group I mGluRs to SNBs in models of neuropathic and inflammatory pain.
Department of Psychology, McGill University, Montreal, Quebec, Canada.
Phoebe E
PE
Scotland
Terence J
TJ
Coderre
D000704:Analysis of Variance; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D004195:Disease Models, Animal; D018690:Excitatory Amino Acid Agonists / Q000008:administration & dosage*; D005620:Freund's Adjuvant; D007839:Functional Laterality; D005998:Glycine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D007249:Inflammation / Q000139:chemically induced / Q000150:complications*; D007278:Injections, Spinal / Q000379:methods; D008297:Male; D010146:Pain / Q000503:physiopathology*; D010147:Pain Measurement; D017288:Pain Threshold / Q000187:drug effects* / Q000502:physiology; D051381:Rats; D020318:Rats, Long-Evans; D012118:Resorcinols / Q000008:administration & dosage*; D020426:Sciatic Neuropathy / Q000150:complications* / Q000209:etiology; D013997:Time Factors
D018690:Excitatory Amino Acid Agonists; D012118:Resorcinols; C079215:3,5-dihydroxyphenylglycine; D005620:Freund's Adjuvant; D005998:Glycine